Aims and scope
Mobile DNA is an online, peer-reviewed, open access journal that publishes articles providing novel insights into DNA rearrangements in all organisms, ranging from transposition and other types of recombination mechanisms to patterns and processes of mobile element and host genome evolution. In addition, the journal will consider articles on the utility of mobile genetic elements in biotechnological methods and protocols.
The average time from submission to a first decision is 24 days.
Mobile DNA aims to understand:
- mechanisms of recombination using genetic, biochemical and structural approaches
- regulation of DNA rearrangements by the environment and during development
- how DNA rearrangements affect cellular function and organism evolution
- mechanisms of host—element interaction
Mobile DNA reflects the need for a journal that spans all aspects of specialized recombination, from evolutionary impact to structure and mechanism. Manuscripts describing DNA rearrangements such as copy number variation are also welcome.
All articles published by Mobile DNA are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Mobile DNA you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Mobile DNA therefore levies an article-processing charge of £1370/$2145/€1745 for each article accepted for publication. If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
Mobile DNA is involved in a pilot study of new technology enabling the setting of article processing charges (APCs) at an article-type level within a journal instead of charging at a flat rate. APCs on this journal are as follows for the duration of the pilot:
|Article type||APC GBP||APC EUR||APC USD|
Payments from within the EU are subject to VAT. EU customers must supply their VAT Number to be exempt from VAT charge. UK Customers are not exempt from VAT charge.
BioMed Central provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
All articles published in Mobile DNA are included in:
- BIOSIS Previews
- JCR/Science edition
- PubMed Central
- Science Citation Index Expanded
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
Mobile DNA has an Impact Factor of 2.520.
Mobile DNA operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Edited by Marlene Belfort, Cédric Feschotte, Haig Kazazian and Henry Levin, Mobile DNA is supported by an expert Editorial Board.
Manuscripts are initially screened by the Editors-in-Chief and suitable manuscripts are sent to at least two reviewers for consideration. Decisions will be made on the recommendations of the reviewers, but final decisions lie with the Editors-in-Chief.
All manuscripts submitted to Mobile DNA should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Citing articles in Mobile DNA
Articles in Mobile DNA should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Mobile DNA [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Mobile DNA 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher.
Why publish your article in Mobile DNA
Mobile DNA's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Mobile DNA offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in Mobile DNA gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Mobile DNA are included in article alerts and regular email updates. Some may be highlighted on Mobile DNA’s pages and on the BioMed Central homepage.
In addition, articles published in Mobile DNA may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Mobile DNA. A list of articles recently press-released by journals published by BioMed Central is available here.
As an author of an article published in Mobile DNA you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.